Separation Anxiety Disorder (SEPAD) is a debilitating psychiatric condition characterised by developmentally inappropriate, excessive fear or anxiety concerning detachment from major attachment figures—typically parents in youth or romantic partners in adulthood. While transient separation fears are normative in toddlers (ages 8-24 months), SEPAD represents a pathological persistence or late onset of this distress, causing clinically significant impairment in social, academic, or occupational functioning. The DSM-5 has removed the previous age-of-onset restriction, formally recognising that this disorder can manifest across the entire lifespan, from early childhood through geriatric years.
The lifetime prevalence of SEPAD is 4.8% in the general adult population, with clinical setting rates soaring between 23% and 69%. While common in children (ages 8-10), adult-onset SEPAD occurs in approximately 20.8% of clinical cases, often triggered by interpersonal trauma. Symptoms must persist for ≥4 weeks in children/adolescents and ≥6 months in adults to meet diagnostic criteria.
Afflicted individuals experience recurrent excessive distress upon separation, persistent worry about losing attachment figures to illness or accident, school or work refusal, separation-themed nightmares, and somatic complaints such as headache or stomachache. In children, dramatic, pleading scenes typically occur at separation, while adults may exhibit avoidance of work, travel, or independent living. Notably, 36% of childhood-onset cases persist into adulthood, and the disorder frequently co-occurs with panic disorder, generalised anxiety, and major depression.
Research implicates altered oxytocin receptor function, structural brain changes, and genetic predisposition in the aetiology of SEPAD. Life stressors—death of a relative, geographic relocation, or even the collective trauma of events like the COVID-19 pandemic—can trigger onset. First-line intervention is Cognitive Behavioural Therapy (CBT), incorporating gradual exposure and parental coaching on matter-of-fact separations. For severe, refractory cases, SSRIs (selective serotonin reuptake inhibitors) may be adjunctively utilised, though experience in very young children remains limited.
Separation Anxiety Disorder is a prevalent, frequently underdiagnosed condition that imposes a profound burden across the lifespan—impeding educational attainment, professional independence, and relational security. With its formal recognition as an adult-onset, trauma-related entity, clinicians must maintain heightened vigilance for this disorder beyond pediatric settings. Through systematic behavioural intervention and, when indicated, pharmacotherapy, individuals can unshackle themselves from the relentless fear of disconnection, reclaiming autonomy and the capacity for healthy, secure attachments.
